What the cited study examined

The cited 2014 study compared urinary microbiome findings in women with and without urgency urinary incontinence. It provides a research example of an association, not a clinical trial of FEMICORE or a demonstration that this supplement changes symptoms.

[microbiome]

Why association is not a prescription

Groups can differ in multiple ways. Even a reproducible bacterial difference would leave questions about cause, consequence, and whether changing that feature changes outcomes. A treatment claim requires evidence of the intervention, not only a description of the condition.

Oral products introduce additional questions

Which organisms, which strains, what dose, what route, and what outcome are involved? Does the product provide viable-count information? Does the trial use the same preparation? Those details are necessary before connecting a capsule to research about a body site.

Read claims at the right level

Statements that a product “balances” or “restores” a microbiome need a definition and supporting evidence. Without those, the words can imply more certainty than the study provides. Our probiotic guide compares the supplied label identifiers and explains why a blend weight does not disclose CFUs.

A useful next step

Continue with FEMICORE Probiotics: Strains, CFUs & Evidence. Keep a short list of questions to discuss with a qualified professional. This article is educational, has not been medically reviewed, and does not establish a treatment plan.

Continue your research

References & source notes

  1. Pearce et al., 2014: Female urinary microbiome and urgency incontinence. Accessed September 25, 2026.

Label information comes from the supplied artwork. Seller claims are not independent clinical evidence. Sources do not imply endorsement of this site or FEMICORE.